Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Agni-modulating Ayurvedic Intervention in Allergic Rhinitis
NCT07626099Not yet recruiting
- Sponsor
- Amrita Vishwa Vidyapeetham
- Start
- Jun 2028
- Primary completion
- Dec 2029
01
Overview
Randomised, single-blind trial in allergic rhinitis (AR) (2 arms), sponsored by Amrita Vishwa Vidyapeetham. Primary endpoints: Serum Immunoglobulin E at 4 weeks, Serum Interleukin-4 at 4 weeks and 1 more. Planned start Jun 2028; status: not yet recruiting.
02
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT07626099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07626099.